Literature DB >> 10654907

Clinical results of fetal obstructive uropathy treated by vesicoamniotic shunting.

Y Makino1, H Kobayashi, K Kyono, K Oshima, T Kawarabayashi.   

Abstract

OBJECTIVES: To report the clinical results of 5 fetuses after a vesicoamniotic shunting procedure (VASP).
METHODS: Between 1995 and 1998, 5 patients (two with prune belly syndrome, one with a cloacal anomaly, one with urethral stenosis, and one with a sacrococcygeal teratoma) underwent VASP using a double-basket catheter. We used the following selection criteria: a fetus without chromosomal defects, with oligohydramnios, and with a predicted good renal function from sequential or single fetal urinalysis (sodium concentration, chloride concentration, and osmolarity at less than 100 mEq/L, less than 90 mEq/L, and less than 210 mOsm, respectively).
RESULTS: The mean gestational age was 20.8 +/- 6.9 weeks at diagnosis, 24.2 +/- 6.0 weeks at VASP, and 30.6 +/- 6.2 weeks at delivery. In our study, 2 of 5 patients survived. One of the patients with prune belly syndrome was 18 months old at last follow-up, with hydrocephalus and a creatinine level of 0.2 mg/dL. The patient with the cloacal anomaly was 4 years old at last follow-up and had signs of clonic convulsion. However, psychomotor development was delayed in both. Of the 3 patients who died, 2 died after birth, and the autopsy determined death was due to pulmonary insufficiency. The patient with urethral stenosis died in utero.
CONCLUSIONS: Although the principal purpose of VASP is to prevent pulmonary hypoplasia and dysfunctional kidneys, VASP was not always effective, as the outcomes were poor in most of our patients. A greater standardization of patient selection and a large cohort study in the future should be considered to assess VASP.

Entities:  

Mesh:

Year:  2000        PMID: 10654907     DOI: 10.1016/s0090-4295(99)00403-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  1 in total

1.  Development of an animal model to study congenital urinary obstruction.

Authors:  K C Pringle; H Kitagawa; Y Seki; J Koike; J Zuccollo
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.